Michelle M Dugan

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Glycemic Control

Basal Cell Carcinoma

Top Venues

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle M Dugan, Matthew C Perez, Lilit Karapetyan, Jonathan S Zager
Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation-Positive Melanoma: Patient Selection and Perspectives. Cancer management and research 16 (2024)
Michelle M Dugan, Matthew C Perez, Lilit Karapetyan, Jonathan S Zager
Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation-Positive Melanoma: Patient Selection and Perspectives. Cancer management and research 16 (2024)